Total Payments
$8,603
2024 Payments
$3,025
Companies
46
Transactions
469
Medicare Patients
519
Medicare Billing
$50,956
Payment Breakdown by Category
Food & Beverage$8,600 (100.0%)
Travel$2.92 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,600 | 468 | 100.0% |
| Travel and Lodging | $2.92 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,189 | 120 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,181 | 56 | $0 (2024) |
| Lilly USA, LLC | $889.96 | 47 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $689.44 | 43 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $534.45 | 29 | $0 (2024) |
| Novo Nordisk Inc | $398.48 | 28 | $0 (2024) |
| Astellas Pharma US Inc | $293.18 | 13 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $266.93 | 18 | $0 (2023) |
| PFIZER INC. | $265.58 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $233.80 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,025 | 161 | ABBVIE INC. ($488.19) |
| 2023 | $2,812 | 152 | ABBVIE INC. ($721.38) |
| 2022 | $2,731 | 153 | ABBVIE INC. ($979.05) |
| 2021 | $35.57 | 3 | GlaxoSmithKline, LLC. ($35.57) |
All Payment Transactions
469 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: PAIN | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.39 | General |
| 12/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: VACCINES | ||||||
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: GI | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: VACCINES | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: Insulin Pump | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Biological | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: PAIN | ||||||
| 11/05/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $0.77 | General |
| Category: GI | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.27 | General |
| Category: GI | ||||||
| 11/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: Biological | ||||||
| 10/24/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 164 | 297 | $43,200 | $14,127 |
| 2022 | 4 | 96 | 220 | $36,995 | $12,391 |
| 2021 | 4 | 117 | 239 | $34,464 | $12,660 |
| 2020 | 5 | 142 | 257 | $36,224 | $11,777 |
Total Patients
519
Total Services
1,013
Medicare Billing
$50,956
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 156 | $31,200 | $9,254 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $4,000 | $1,657 | 41.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 21 | 22 | $2,200 | $1,359 | 61.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 23 | $4,025 | $1,194 | 29.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 20 | 20 | $500.00 | $296.60 | 59.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 15 | 15 | $375.00 | $222.45 | 59.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 21 | 45 | $900.00 | $144.45 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 155 | $31,000 | $10,260 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $3,250 | $1,377 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $1,925 | $621.85 | 32.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 17 | 41 | $820.00 | $132.51 | 16.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 157 | $28,544 | $10,518 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 16 | 16 | $4,000 | $1,725 | 43.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 11 | 20 | $1,000 | $266.00 | 26.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 23 | 46 | $920.00 | $150.88 | 16.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 78 | 169 | $28,054 | $9,100 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 13 | 13 | $3,250 | $1,223 | 37.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 30 | $3,450 | $886.05 | 25.7% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 13 | 19 | $950.00 | $483.30 | 50.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 17 | 26 | $520.00 | $84.93 | 16.3% |
About Cindy Koplitz
Cindy Koplitz is a Nurse Practitioner healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2014. The National Provider Identifier (NPI) number assigned to this provider is 1982026043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cindy Koplitz has received a total of $8,603 in payments from pharmaceutical and medical device companies, with $3,025 received in 2024. These payments were reported across 469 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($8,600).
As a Medicare-enrolled provider, Koplitz has provided services to 519 Medicare beneficiaries, totaling 1,013 services with total Medicare billing of $50,956. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Milwaukee, WI
- Active Since 01/09/2014
- Last Updated 09/16/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982026043
Products in Payments
- VRAYLAR (Drug) $784.43
- Linzess (Drug) $689.44
- FARXIGA (Drug) $620.56
- Kerendia (Drug) $534.45
- MOUNJARO (Drug) $519.77
- LINZESS (Drug) $423.98
- UBRELVY (Drug) $348.67
- ZENPEP (Drug) $334.09
- BREZTRI (Drug) $296.27
- Veozah (Drug) $276.14
- Wegovy (Drug) $267.12
- AIRSUPRA (Drug) $243.70
- XIFAXAN (Drug) $229.04
- NURTEC ODT (Drug) $221.94
- Cologuard Collection Kit (Device) $213.92
- TRULICITY (Drug) $201.34
- CREON (Drug) $155.67
- IBSRELA (Drug) $146.75
- VIBERZI (Drug) $134.50
- QULIPTA (Drug) $133.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Milwaukee
Ms. Trisha Wilcox, Apnp, APNP
Nurse Practitioner — Payments: $85,644
Nurse Practitioner $85,644
Ms. Kelly Flugaur, Np, NP
Nurse Practitioner — Payments: $38,269
Nurse Practitioner $38,269
Ms. Sherry Aleksich, Np, NP
Nurse Practitioner — Payments: $26,812
Nurse Practitioner $26,812
Ms. Mary Elizabeth Nelson-Biersach, Np, NP
Nurse Practitioner — Payments: $17,886
Nurse Practitioner $17,886
Mrs. Ngozi Obiora, Fnp, FNP
Nurse Practitioner — Payments: $13,070
Nurse Practitioner $13,070
Ms. Cheryl Blaschuk, Np, NP
Nurse Practitioner — Payments: $10,465
Nurse Practitioner $10,465